These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
160 related items for PubMed ID: 9380734
1. A single in vivo administration of bombesin antagonist RC-3095 reduces the levels and mRNA expression of epidermal growth factor receptors in MXT mouse mammary cancers. Szepeshazi K, Schally AV, Halmos G, Lamharzi N, Groot K, Horvath JE. Proc Natl Acad Sci U S A; 1997 Sep 30; 94(20):10913-8. PubMed ID: 9380734 [Abstract] [Full Text] [Related]
2. Growth inhibition of estrogen-dependent and estrogen-independent MXT mammary cancers in mice by the bombesin and gastrin-releasing peptide antagonist RC-3095. Szepeshazi K, Schally AV, Halmos G, Groot K, Radulovic S. J Natl Cancer Inst; 1992 Dec 16; 84(24):1915-22. PubMed ID: 1460673 [Abstract] [Full Text] [Related]
3. Bombesin/gastrin-releasing peptide antagonists RC-3095 and RC-3940-II inhibit tumor growth and decrease the levels and mRNA expression of epidermal growth factor receptors in H-69 small cell lung carcinoma. Koppán M, Halmos G, Arencibia JM, Lamharzi N, Schally AV. Cancer; 1998 Oct 01; 83(7):1335-43. PubMed ID: 9762934 [Abstract] [Full Text] [Related]
4. Reduction in receptors for bombesin and epidermal growth factor in xenografts of human small-cell lung cancer after treatment with bombesin antagonist RC-3095. Halmos G, Schally AV. Proc Natl Acad Sci U S A; 1997 Feb 04; 94(3):956-60. PubMed ID: 9023364 [Abstract] [Full Text] [Related]
5. Antagonists of growth hormone releasing hormone (GHRH) and of bombesin/gastrin releasing peptide (BN/GRP) suppress the expression of VEGF, bFGF, and receptors of the EGF/HER family in PC-3 and DU-145 human androgen-independent prostate cancers. Stangelberger A, Schally AV, Varga JL, Hammann BD, Groot K, Halmos G, Cai RZ, Zarandi M. Prostate; 2005 Aug 01; 64(3):303-15. PubMed ID: 15754342 [Abstract] [Full Text] [Related]
6. Effect of bombesin, gastrin-releasing peptide (GRP)(14-27) and bombesin/GRP receptor antagonist RC-3095 on growth of nitrosamine-induced pancreatic cancers in hamsters. Szepeshazi K, Schally AV, Groot K, Halmos G. Int J Cancer; 1993 May 08; 54(2):282-9. PubMed ID: 8387464 [Abstract] [Full Text] [Related]
13. Inhibitory effect of bombesin/gastrin-releasing peptide (GRP) antagonists RC-3950-II and RC-3095 on MCF-7 MIII human breast cancer xenografts in nude mice. Shirahige Y, Cai RZ, Szepeshazi K, Halmos G, Pinski J, Groot K, Schally AV. Biomed Pharmacother; 1994 May 08; 48(10):465-72. PubMed ID: 7858155 [Abstract] [Full Text] [Related]
15. Inhibition of growth of MDA-MB-231 human breast cancer xenografts in nude mice by bombesin/gastrin-releasing peptide (GRP) antagonists RC-3940-II and RC-3095. Miyazaki M, Lamharzi N, Schally AV, Halmos G, Szepeshazi K, Groot K, Cai RZ. Eur J Cancer; 1998 Apr 08; 34(5):710-7. PubMed ID: 9713279 [Abstract] [Full Text] [Related]
16. Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice. Pinski J, Schally AV, Halmos G, Szepeshazi K, Groot K, O'Byrne K, Cai RZ. Br J Cancer; 1994 Nov 08; 70(5):886-92. PubMed ID: 7947094 [Abstract] [Full Text] [Related]
17. Inhibition of growth of OV-1063 human epithelial ovarian cancers and c- jun and c- fos oncogene expression by bombesin antagonists. Chatzistamou I, Schally AV, Sun B, Armatis P, Szepeshazi K. Br J Cancer; 2000 Oct 08; 83(7):906-13. PubMed ID: 10970693 [Abstract] [Full Text] [Related]
18. Inhibition of growth of human malignant glioblastoma in nude mice by antagonists of bombesin/gastrin-releasing peptide. Kiaris H, Schally AV, Sun B, Armatis P, Groot K. Oncogene; 1999 Nov 25; 18(50):7168-73. PubMed ID: 10597318 [Abstract] [Full Text] [Related]